Biodesix, Inc.

Biodesix (BDSX) Shares Plunge Following Sales Force Disclosures: Johnson Fistel’s Colorado Office Initiates Investigation

Johnson Fistel, PLLP, a national shareholder rights law firm with an office in Denver, Colorado, has begun investigating potential securities claims on behalf of Biodesix, Inc. (NASDAQ: BDSX) investors following the Company’s sharp stock decline on November 6, 2026. The investigation concerns whether Biodesix, a Louisville, Colorado-based diagnostic solutions company, or its officers made materially false or misleading statements or failed to disclose material information to investors.

What if I purchased Biodesix securities?

Name

This field is for validation purposes and should be left unchanged.

If you suffered a loss on your investment and would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. The information provided will be held in strict confidence unless and until you authorize us to disclose it.

Name(Required)

First Last

Email(Required)

Phone(Required)

Estimated Losses(Required)

Where did you see our press release?(Required)

If you selected 'Other' above, please specify below:(Required)

Would you like to receive future case and securities updates from Johnson Fistel, PLLP via email?(Required)

Yes

Would you like to receive information about Johnson Fistel, PLLP's free portfolio monitoring service?(Required)

Yes

By selecting yes, I agree to receive marketing text messages and calls from Johnson Fistel, PLLP at the phone number provided. I understand these messages may be sent using an automatic dialing system, that consent is not a condition of purchase or receipt of services, and that message & data rates may apply. I can reply HELP for help or STOP to cancel. See our Privacy Policy and Terms.(Required)

Yes

By checking the box, I acknowledge that this form is not intended to and does not establish an attorney-client relationship between myself and Johnson Fistel, PLLP, and that submission to or receipt of information from the firm or one of its attorneys via this form, website, email, or telephone does not create an attorney-client relationship.(Required)

I Agree

You may also contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471. There is no cost or obligation to you.

What prompted the investigation?

On November 5, 2026, Biodesix reported third-quarter revenue of $24.0 million and reduced its full-year 2026 revenue guidance to $101 million to $103 million, down from its prior guidance of $108 million to $114 million. The Company attributed its disappointing growth in part to challenges involving its sales force, including staffing issues.

Following these disclosures, Biodesix shares declined approximately 48% during intraday trading on November 6, 2026.

Who Is Johnson Fistel, PLLP?

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm’s Colorado office is located in Denver. Johnson Fistel represents individual and institutional investors in shareholder derivative and securities class action lawsuits. The firm also represents foreign investors who have purchased securities on U.S. exchanges.

Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Don’t Miss Key Updates on Your Stock Holdings!

Join JF Alerts. We’ll send you timely updates regarding our cases and investigations.

It’s free. No cost, no obligation. Unsubscribe at any time.

We respect your privacy. Johnson Fistel, PLLP does not share your information with others.

The submission of this form does not establish an attorney-client relationship with Johnson Fistel, PLLP.